Intestinal fibrosis is reduced by early elimination of inflammation in a mouse model of IBD: Impact of a “Top-Down” approach to intestinal fibrosis in mice

Review article: remission rates achievable by current therapies for inflammatory bowel disease

(2011) L. Peyrin-Biroulet et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Transient or persistent norovirus infection does not alter the pathology of Salmonella typhimurium induced intestinal inflammation and fibrosis in mice

(2011) Peter D.R. Higgins et al.   COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES

Trends in Surgery for Crohnʼs Disease in the Era of Infliximab

(2010) Douglas W. Jones et al.   ANNALS OF SURGERY

Proinflammatory cytokines underlying the inflammation of Crohnʼs disease

(2010) Warren Strober et al.   CURRENT OPINION IN GASTROENTEROLOGY

What is the optimal therapy for Crohn’s disease: step-up or top-down?

(2010) Ming Valerie Lin et al.   Expert Review of Gastroenterology & Hepatology

Top-Down Therapy: Is the Evidence Strong Enough?

(2009) Eugeni Domènech et al.   DIGESTIVE DISEASES

Medical Management of Crohn’s Disease: Treatment Algorithms 2009

(2009) Stephen B. Hanauer   DIGESTIVE DISEASES

Can We Modulate the Clinical Course of Inflammatory Bowel Diseases by Our Current Treatment Strategies?

(2009) Jacques Cosnes   DIGESTIVE DISEASES

Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease

(2009) S. Brand   GUT

Chronic Enteric Salmonella Infection in Mice Leads to Severe and Persistent Intestinal Fibrosis

(2008) Guntram A. Grassl et al.   GASTROENTEROLOGY